TILT Holdings (TLLTF) Depreciation & Amortization (CF) (2021 - 2025)

TILT Holdings (TLLTF) reported Depreciation & Amortization (CF) of $1.1 million for Q2 2025, down 41.44% on a YoY basis from $1.9 million in Q2 2024, and down 67.23% quarter-over-quarter from $3.4 million in Q1 2025.

TILT Holdings (TLLTF) Depreciation & Amortization (CF) (2021 - 2025) Analysis & Trends

TILT Holdings has reported Depreciation & Amortization (CF) for 5 years, with the latest figure at $1.1 million in Q2 2025.

  • For the quarter ending Q2 2025, Depreciation & Amortization (CF) fell 41.44% year-over-year to $1.1 million; the trailing twelve-month figure through Jun 2025 stood at $16.9 million (changed 0.34% YoY), and the FY2024 full-year result was $19.3 million, down 10.66% from the prior year.
  • Depreciation & Amortization (CF) for Q2 2025 stood at $1.1 million, down from $3.4 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $7.7 million in Q3 2024, with the low at $1.1 million in Q2 2025.
  • Historically, Depreciation & Amortization (CF) has averaged $4.9 million across 5 years, with a median of $5.5 million in 2023.
  • Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 302.51% — and 2024, when it tumbled 68.23%.
  • TILT Holdings' Depreciation & Amortization (CF) stood at $5.9 million in 2021, then climbed by 3.19% to $6.1 million in 2022, then declined by 17.69% to $5.0 million in 2023, then declined by 7.58% to $4.6 million in 2024, then plunged by 75.99% to $1.1 million in 2025.
  • The last three Depreciation & Amortization (CF) figures came in at $1.1 million (Q2 2025), $3.4 million (Q1 2025), and $4.6 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 239.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 119.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 22.60 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 7.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 172.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 19.43 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 21.95 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 22.68 Mn
10 TILT Holdings - - 1.82 Mn 1.12 Mn

Historic Data

Download Data
DateValue
Jun 30, 2025 1.12 Mn
Jun 30, 2025 1.12 Mn
Mar 31, 2025 3.40 Mn
Mar 31, 2025 3.40 Mn
Dec 31, 2024 4.64 Mn
Dec 31, 2024 4.64 Mn
Sep 30, 2024 7.73 Mn
Sep 30, 2024 7.73 Mn
Jun 30, 2024 1.90 Mn
Jun 30, 2024 1.90 Mn
Mar 31, 2024 4.98 Mn
Mar 31, 2024 4.98 Mn
Dec 31, 2023 5.03 Mn
Dec 31, 2023 5.03 Mn
Sep 30, 2023 5.04 Mn
Sep 30, 2023 5.04 Mn
Jun 30, 2023 5.99 Mn
Jun 30, 2023 5.99 Mn
Mar 31, 2023 5.50 Mn
Mar 31, 2023 5.50 Mn